Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain-containing protein 34 (CCDC34) is a member of the large family of coiled-coil domain-containing proteins, notable for a structural motif that supports protein-protein interactions. CCDC34 is expressed highly in the testis and plays a critical role in the structural integrity of sperm flagella by maintaining the axonemal ultrastructure and the assembly or stability of outer dynein arms. Missense or frameshift mutations in CCDC34 cause severe sperm motility defects and are a genetic cause of male infertility (oligoasthenoteratozoospermia)[2]. CCDC34 is also overexpressed in various cancer cells, including hepatocellular carcinoma, where it has been implicated in regulating cell proliferation and migration. However, CCDC34 is not an enzyme, receptor, or traditional therapeutic drug target, and its detailed molecular mechanisms and broader physiological roles remain under active investigation[2].
Not applicable; no known drugs targeting CCDC34
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 34 (CCDC34).